HM2014-26 DT2219 immunotoxin for the treatment of relaps

  • Bachanova, Veronika (PI)

Project: Research project

Project Details

Description

HM2014-26 DT2219 immunotoxin for the treatment of relapsed or refractory CD19 (+) and/or CD 22 (+) Blineage leukemia or lymphoma
StatusActive
Effective start/end date12/19/1412/30/20

Funding

  • GT BIOPHARMA, INC

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.